Objective:To contrast the clinical effcacy of insulin sensitizers Rosiglitazone(Advandia)and traditional Metf ormin on patients with type2diabetes mellitus(DM).

• 目的 :对比探讨胰岛素增敏剂罗格列酮和传统药物二甲双胍治疗2型糖尿病的临床疗效。